A Phase II Study of Pazopanib in Patients With Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST)
Phase of Trial: Phase II
Latest Information Update: 10 Apr 2017
At a glance
- Drugs Pazopanib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 22 Feb 2017 Status changed from active, no longer recruiting to discontinued.
- 14 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 Jul 2011 New trial record